Reverse Merger - Additional Information (Details) - USD ($) |
Feb. 28, 2022 |
Feb. 28, 2021 |
Feb. 29, 2020 |
|---|---|---|---|
| Reverse Merger [Line Items] | |||
| Ordinary shares issued | 81,364,337 | 5,000,000 | |
| At Fair Value | Reverse Merger | |||
| Reverse Merger [Line Items] | |||
| Aggregate reverse merger in cash | $ 60,000,000 | ||
| Fair value of issued equity amount | $ 525,000,000 | ||
| Ordinary shares issued | 51,622,419 | ||
| Fair value of issued equity per share | $ 10.17 |
| X | ||||||||||
- Definition The amount instruments representing equity (rather than debt) contribute to the fair value of defined benefit plan assets. [Refer: Plan assets, at fair value; Defined benefit plans [member]] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The number of shares issued by the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of instruments purchased for resale in reverse repurchase agreements and cash collateral on securities borrowed. [Refer: Repurchase agreements and cash collateral on securities lent] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Reverse merger. No definition available.
|
| X | ||||||||||
- Definition Share issued price per share. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|